What Types of Cancer are Treated with DNA Methylation Inhibitors?
DNA methylation inhibitors have shown efficacy in treating hematologic malignancies, particularly MDS and AML. However, ongoing research is exploring their potential in solid tumors, such as colorectal, lung, and breast cancer. The effectiveness of these inhibitors in solid tumors is still under investigation, and combination therapies with other epigenetic drugs or conventional treatments are being evaluated to improve outcomes.
